https://ergomedgroup.com/news/ergomed-acquires-medsource-a-us-based-specialist-oncology-and-rare-disease-cro/ 2022-02-15T15:02:29+00:00 https://ergomedgroup.com/wp-content/uploads/2019/07/ergomed-logo-512-1.png https://ergomedgroup.com/events/ergomed-presenting-at-jefferies-virtual-london-2020-healthcare-conference/ 2022-02-15T15:02:29+00:00 https://ergomedgroup.com/events/9th-global-patients-congress-virtual-event/ 2022-02-15T15:02:29+00:00 https://ergomedgroup.com/news/article-in-rare-revolution-magazine/ 2022-02-15T15:02:29+00:00 https://ergomedgroup.com/wp-content/uploads/2020/10/Bojana-Rare-Revolution.jpg https://ergomedgroup.com/events/pharma-patient-europe-2020-digital-conference-expo/ 2022-02-15T15:02:29+00:00 https://ergomedgroup.com/events/esmo-virtual-congress-2020/ 2022-02-15T15:02:29+00:00 https://ergomedgroup.com/news/how-can-ergomed-support-you-in-executing-clinical-trials-during-covid-19/ 2022-02-15T15:02:30+00:00 https://ergomedgroup.com/wp-content/uploads/2020/03/iStock-covid19.jpg https://ergomedgroup.com/news/webinar-recording-ensuring-continuity-in-rare-disease-clinical-trials-during-the-covid-19-crisis/ 2022-02-15T15:02:30+00:00 https://ergomedgroup.com/wp-content/uploads/2020/05/Webinar-recording-1.jpg https://ergomedgroup.com/news/ergomed-to-present-at-jefferies-virtual-2020-healthcare-conference/ 2022-02-15T15:02:30+00:00 https://ergomedgroup.com/wp-content/uploads/2020/05/Richard-Barfield-Jefferies-Conference-Website-4.jpg https://ergomedgroup.com/news/dr-elliot-brown-one-of-primevigilance-founding-directors-offers-valuable-support-for-covid-19-studies/ 2022-02-15T15:02:30+00:00 https://ergomedgroup.com/wp-content/uploads/2020/06/Elliot-Brown-Website-2.jpg https://ergomedgroup.com/news/ergomeds-psr-orphan-experts-exhibiting-at-digital-event-on-orphan-drugs-and-rare-diseases/ 2022-02-15T15:02:30+00:00 https://ergomedgroup.com/wp-content/uploads/2020/07/Orphan-Drugs_Sponsor_500x350_PSR-Orphan-Drugs-LI.jpg https://ergomedgroup.com/events/virtual-advanced-therapies-congress-expo-2020/ 2022-02-15T15:02:30+00:00 https://ergomedgroup.com/events/world-orphan-drug-congress-usa-2020-virtual/ 2022-02-15T15:02:30+00:00 https://ergomedgroup.com/events/digital-event-on-orphan-drugs-and-rare-diseases/ 2022-02-15T15:02:30+00:00 https://ergomedgroup.com/events/pcmg-live-2020-virtual-event/ 2022-02-15T15:02:30+00:00 https://ergomedgroup.com/news/webinar-drug-repurposing-for-covid-19/ 2022-02-15T15:02:30+00:00 https://ergomedgroup.com/wp-content/uploads/2020/05/Final-for-website-1.jpg https://ergomedgroup.com/news/edison-tv-executive-interview-with-ergomeds-cfo-richard-barfield/ 2022-02-15T15:02:30+00:00 https://ergomedgroup.com/wp-content/uploads/2020/08/Edison_Richard-Barfield_Aug2020-4-1.jpg https://ergomedgroup.com/news/ergomed-fully-compliant-under-mydata-trusts-label-good-data-protection-practice/ 2022-02-15T15:02:30+00:00 https://ergomedgroup.com/wp-content/uploads/2020/08/GDPR-MyData-Label-2_website-2.png https://ergomedgroup.com/news/ergomed-enters-strategic-collaboration-to-drive-pharmacovigilance-leadership-in-intelligent-automation/ 2022-02-15T15:02:30+00:00 https://ergomedgroup.com/wp-content/uploads/2020/05/Automation-Anywhere-Data-Robot-PV-Twitter-image-Post-1532-x-1144.png https://ergomedgroup.com/news/ergomed-announces-provision-of-clinical-research-services-for-covid-19-clinical-study/ 2022-02-15T15:02:31+00:00 https://ergomedgroup.com/wp-content/uploads/2020/03/iStock-covid19.jpg https://ergomedgroup.com/news/a-message-from-ergomed-plc-executive-chairman-dr-miroslav-reljanovic-ergomed-response-to-covid-19/ 2022-02-15T15:02:31+00:00 https://ergomedgroup.com/wp-content/uploads/2019/04/EM.jpg https://ergomedgroup.com/news/ergomed-team-discuss-new-covid-19-project-and-transformational-2019/ 2022-02-15T15:02:31+00:00 https://ergomedgroup.com/wp-content/uploads/2020/03/Corona-Proactive-interview-25-March.jpg https://ergomedgroup.com/news/ergomed-webinar-ensuring-continuity-in-rare-disease-clinical-trials-during-the-covid-19-crisis/ 2022-02-15T15:02:31+00:00 https://ergomedgroup.com/wp-content/uploads/2020/03/COVID-19-Webinar-LinkedIn-1200x630-1.png https://ergomedgroup.com/news/see-you-at-clinical-operations-in-oncology-trials-europe/ 2022-02-15T15:02:31+00:00 https://ergomedgroup.com/wp-content/uploads/2019/11/Oncology-Trials-small-1.png https://ergomedgroup.com/news/update-on-siltuximab-clinical-study-interim-analysis-data-for-siltuximab-treated-covid-19-patients/ 2022-02-15T15:02:31+00:00 https://ergomedgroup.com/wp-content/uploads/2020/04/EUSA.jpg https://ergomedgroup.com/news/seasons-greetings/ 2022-02-15T15:02:31+00:00 https://ergomedgroup.com/wp-content/uploads/2019/12/Ergomed-Festive-e-Card.jpg https://ergomedgroup.com/wp-content/uploads/2019/12/Ergomed-Festive-e-Card.jpg https://ergomedgroup.com/news/san-francisco-meetings-13-16-jan/ 2022-02-15T15:02:31+00:00 https://ergomedgroup.com/wp-content/uploads/2020/01/SFO.jpg https://ergomedgroup.com/news/acquisition-of-ashfield-pharmacovigilance-inc-a-us-pharmacovigilance-services-provider-from-udg-healthcare-for-10-million/ 2022-02-15T15:02:31+00:00 https://ergomedgroup.com/wp-content/uploads/2020/01/world-business-teamwork-puzzle-pieces-picture-ORIGINAL.jpg https://ergomedgroup.com/news/ergomed-announces-provision-of-clinical-research-services-for-second-covid-19/ 2022-02-15T15:02:31+00:00 https://ergomedgroup.com/wp-content/uploads/2020/04/image-vial-bg.jpg https://ergomedgroup.com/news/join-free-webinar-ergomed-and-the-road-to-gdpr-compliance/ 2022-02-15T15:02:31+00:00 https://ergomedgroup.com/wp-content/uploads/2020/01/Web-Announce-2.png https://ergomedgroup.com/news/sponsoring-drug-repurposing-for-rare-diseases-conference-london/ 2022-02-15T15:02:31+00:00 https://ergomedgroup.com/wp-content/uploads/2020/02/LinkedIn-Post-FindaCure-2.png https://ergomedgroup.com/news/see-you-at-esmo-congress-2019/ 2022-02-15T15:02:32+00:00 https://ergomedgroup.com/wp-content/uploads/2019/09/ESMO-2019-Announcement.png https://ergomedgroup.com/news/where-to-meet-us-in-2019/ 2022-02-15T15:02:32+00:00 https://ergomedgroup.com/wp-content/uploads/2019/10/website.png https://ergomedgroup.com/news/see-you-at-bio-2019/ 2022-02-15T15:02:32+00:00 https://ergomedgroup.com/wp-content/uploads/2019/06/bio-convention-iLinked-In.jpg https://ergomedgroup.com/news/annual-pcmg-conference-sitges/ 2022-02-15T15:02:32+00:00 https://ergomedgroup.com/wp-content/uploads/2019/06/sitges-1477826_1280.jpg https://ergomedgroup.com/news/meet-us-at-bio-europe-2019/ 2022-02-15T15:02:32+00:00 https://ergomedgroup.com/wp-content/uploads/2019/10/Ergomed-BIO-Europe-2-FACEBOOK-POST-1200-X-630-1.png https://ergomedgroup.com/news/see-you-in-frankfurt-at-wodc-europe-2019/ 2022-02-15T15:02:32+00:00 https://ergomedgroup.com/wp-content/uploads/2019/11/Orphan-Drug-Social-Ergomed.png https://ergomedgroup.com/news/ergomed-real-world-evidence-newsletter/ 2022-02-15T15:02:32+00:00 https://ergomedgroup.com/wp-content/uploads/2019/11/RWE-newsletter-2.png https://ergomedgroup.com/news/join-free-webinar-involving-the-patient-community-in-rare-disease-clinical-trials/ 2022-02-15T15:02:32+00:00 https://ergomedgroup.com/wp-content/uploads/2019/11/Webinar-2019-12-03-RARE.png https://ergomedgroup.com/news/orphan-drugs-and-rare-diseases-global-congress-2019-americas/ 2022-02-15T15:02:32+00:00 https://ergomedgroup.com/wp-content/uploads/2019/09/orphan-drugs-boston.png https://ergomedgroup.com/news/see-you-at-raresummit19/ 2022-02-15T15:02:32+00:00 https://ergomedgroup.com/wp-content/uploads/2019/09/Cambridge-Rare-summit.png https://ergomedgroup.com/news/ergomed-exhibiting-at-oct-new-england-02-03-oct/ 2022-02-15T15:02:32+00:00 https://ergomedgroup.com/wp-content/uploads/2019/09/OCT-Announcement-Booth-64-2.png https://ergomedgroup.com/news/ergomeds-primevigilance-awarded-2019-queens-award-for-enterprise/ 2022-02-15T15:02:33+00:00 https://ergomedgroup.com/wp-content/uploads/2018/04/resource-tile-3.png https://ergomedgroup.com/news/ergomed-on-track-to-exceed-2019-market-expectations-following-a-strong-start-to-the-year/ 2022-02-15T15:02:33+00:00 https://ergomedgroup.com/wp-content/uploads/2018/04/resource-tile-3.png https://ergomedgroup.com/news/eaaci-congress-2019/ 2022-02-15T15:02:33+00:00 https://ergomedgroup.com/wp-content/uploads/2019/05/EAACI-small-houses.jpg https://ergomedgroup.com/news/2019-asco-annual-meeting/ 2022-02-15T15:02:33+00:00 https://ergomedgroup.com/wp-content/uploads/2019/05/asco_2019_big-2.jpg https://ergomedgroup.com/news/ergomed-primevigilance-latest-free-webinar/ 2022-02-15T15:02:33+00:00 https://ergomedgroup.com/wp-content/uploads/2019/05/Pharmacoepidemiology-and-Risk-ManagementSolutions-Copy.jpg https://ergomedgroup.com/news/ergomed-shortlisted-for-best-technological-development-in-clinical-trials-at-scrip-awards-2018/ 2022-02-15T15:02:33+00:00 https://ergomedgroup.com/wp-content/uploads/2018/11/scrip-1-e1541774905731-plain.jpg https://ergomedgroup.com/news/watch-ergomed-psr-webinar-rare-disease-patients-in-the-middle-east-and-north-africa-mena-leveraging-unique-real-world-data-opportunities/ 2022-02-15T15:02:33+00:00 https://ergomedgroup.com/wp-content/uploads/2018/11/200x150-ergomed-002-06-Nov-Webinar-front-page-1.jpg https://ergomedgroup.com/news/ergomed-congratulates-octapharma-on-gaining-marketing-authorisation-for-fibryga-in-switzerland/ 2022-02-15T15:02:33+00:00 https://ergomedgroup.com/wp-content/uploads/2019/01/Fibryga-Octapharma.jpg https://ergomedgroup.com/news/ergomed-awarded-by-the-medicines-medical-devices-agency-of-serbia/ 2022-02-15T15:02:33+00:00 https://ergomedgroup.com/wp-content/uploads/2019/01/ALIMS-edited.jpg https://ergomedgroup.com/news/https-www-ngocommitteerarediseases-org-rare-disease-day-policy-event-at-the-united-nations/ 2022-02-15T15:02:33+00:00 https://ergomedgroup.com/wp-content/uploads/2019/02/bigbox-20feb2019.jpg https://ergomedgroup.com/news/rare-disease-day-press-release/ 2022-02-15T15:02:33+00:00 https://ergomedgroup.com/wp-content/uploads/2019/02/Rare-Disease-Countdown-today-smaller.jpg https://ergomedgroup.com/news/ergomed-at-digital-health-technology-show-london/ 2022-02-15T15:02:33+00:00 https://ergomedgroup.com/wp-content/uploads/2019/03/logo.png https://ergomedgroup.com/news/5th-neuroblastoma-research-symposium/ 2022-02-15T15:02:33+00:00 https://ergomedgroup.com/wp-content/uploads/2019/04/iJFcA5of.jpg https://ergomedgroup.com/news/ergomed-notes-announcement-by-co-development-partner-aeterna-zentaris-of-results-from-phase-3-clinical-trial-with-zoptrex-in-advanced-endometrial-cancer/ 2022-02-15T15:02:34+00:00 https://ergomedgroup.com/news/ergomeds-primevigilance-hosts-prestigious-intelligent-automation-seminar-for-the-international-society-of-pharmacovigilance/ 2022-02-15T15:02:34+00:00 https://ergomedgroup.com/news/completion-of-acquisition-of-psr-group-bv-a-specialist-orphan-drug-cro/ 2022-02-15T15:02:34+00:00 https://ergomedgroup.com/news/ergomeds-primevigilance-adds-specialist-pharmacoepidemiology-services-with-key-hire/ 2022-02-15T15:02:34+00:00 https://ergomedgroup.com/wp-content/uploads/2018/04/resource-tile-7.png https://ergomedgroup.com/news/ergomed-strengthens-primevigilance-with-acquisition-of-european-pharmacovigilance-and-regulatory-services-business-pharminvent/ 2022-02-15T15:02:34+00:00 https://ergomedgroup.com/news/psr-orphan-experts-ergomeds-rare-disease-specialist-division-organises-fundraiser-to-support-global-rare-disease-day-2018/ 2022-02-15T15:02:34+00:00 https://ergomedgroup.com/wp-content/uploads/2018/04/news-disease2030-tile.jpg https://ergomedgroup.com/news/ergomed-to-report-very-strong-2016-revenue-growth-and-order-backlog-poised-for-significant-clinical-milestones-in-2017/ 2022-02-15T15:02:34+00:00 https://ergomedgroup.com/news/peprostat-phase-iib-study-passes-recruitment-mid-point-ahead-of-schedule-top-line-results-brought-forward-to-q4-2017/ 2022-02-15T15:02:34+00:00 https://ergomedgroup.com/news/ergomed-notes-co-development-partner-aeterna-zentaris-completes-zoptrex-pivotal-phase-3-clinical-trial-in-advanced-endometrial-cancer-with-results-expected-in-april/ 2022-02-15T15:02:34+00:00 https://ergomedgroup.com/news/ergomed-announces-positive-phase-ii-top-line-results-of-co-development-partner-ferrers-lorediplon-for-the-treatment-of-insomnia/ 2022-02-15T15:02:34+00:00 https://ergomedgroup.com/news/ergomed-completes-phase-iib-study-recruitment-six-months-ahead-of-schedule-for-its-innovative-coagulant-peprostat/ 2022-02-15T15:02:34+00:00 https://ergomedgroup.com/news/ergomed-notes-co-development-partner-modus-therapeutics-successfully-raises-sek-32-million-2-9m/ 2022-02-15T15:02:34+00:00 https://ergomedgroup.com/news/dr-jan-petracek-selected-as-one-of-the-winners-of-the-2018-dia-inspire-award/ 2022-02-15T15:02:34+00:00 https://ergomedgroup.com/wp-content/uploads/2018/04/news-petracek-tile.jpg https://ergomedgroup.com/news/ergomed-initiates-phase-ii-study-of-topical-peprostat-in-intraoperative-surgical-haemostatis/ 2022-02-15T15:02:34+00:00 https://ergomedgroup.com/news/ergomed-notes-co-development-partner-asarina-pharma-announces-successful-topline-data-for-its-phase-iia-clinical-study-with-sepranolone-in-premenstrual-dysphoric-disorder-pmdd/ 2022-02-15T15:02:34+00:00 https://ergomedgroup.com/news/ergomed-signs-first-commercialisation-deal-for-haemostatix-products/ 2022-02-15T15:02:34+00:00 https://ergomedgroup.com/news/acquisition-of-psr-group-bv-a-specialist-orphan-drug-cro-for-consideration-of-up-to-e5-7-million/ 2022-02-15T15:02:34+00:00 https://ergomedgroup.com/wp-content/uploads/2018/04/news-psr-tile.jpg https://ergomedgroup.com/news/ergomeds-first-in-class-haemostat-peprostat-reports-positive-top-line-results-and-meets-key-endpoints-in-phase-ii-study/ 2022-02-15T15:02:34+00:00 https://ergomedgroup.com/wp-content/uploads/2018/04/news-blood-tile.jpg https://ergomedgroup.com/news/ergomed-expands-its-co-development-pipeline-with-a-multi-product-partnership-with-allergy-therapeutics-for-oral-allergy-immunotherapies/ 2022-02-15T15:02:34+00:00 https://ergomedgroup.com/wp-content/uploads/2018/04/news-allergy-tile.jpg https://ergomedgroup.com/news/ergomeds-full-service-contract-win-validates-strategic-rationale-of-recent-acquisitions/ 2022-02-15T15:02:35+00:00 https://ergomedgroup.com/news/ergomeds-co-development-partner-aeterna-zentaris-inc-announces-a-fourth-licensing-agreement-for-zoptrex-this-time-with-specialised-therapeutics-asia-for-australia-and-new-zealand/ 2022-02-15T15:02:35+00:00 https://ergomedgroup.com/news/ergomed-notes-co-development-partner-dilaforettes-intention-to-conduct-an-initial-public-offering-and-change-of-name-to-modus-therapeutics/ 2022-02-15T15:02:35+00:00 https://ergomedgroup.com/news/ergomed-announces-co-development-agreement-with-asarina-ab/ 2022-02-15T15:02:35+00:00 https://ergomedgroup.com/news/ergomeds-co-development-partner-modus-therapeutics-announces-that-the-independent-data-safety-monitoring-board-endorses-inclusion-of-adolescents-into-the-phase-ii-clinical-study-with-sevupar/ 2022-02-15T15:02:35+00:00 https://ergomedgroup.com/news/proposed-acquisition-of-haemostatix-limited-conditional-placing-of-6433350-initial-placing-shares-at-140-pence-each-conditional-placing-of-up-to-2875000-option-shares-at-140-pence-each-and-notice/ 2022-02-15T15:02:35+00:00 https://ergomedgroup.com/news/ergomeds-co-development-partner-aeterna-zentaris-obtains-positive-recommendation-from-data-safety-monitoring-board/ 2022-02-15T15:02:35+00:00 https://ergomedgroup.com/news/ergomed-acquires-medical-information-service-provider/ 2022-02-15T15:02:35+00:00 https://ergomedgroup.com/news/ergomed-selected-by-co-development-partner-aeterna-zentaris-to-conduct-confirmatory-phase-3-clinical-trial-of-macrilen-in-aghd/ 2022-02-15T15:02:35+00:00 https://ergomedgroup.com/news/ergomeds-co-development-partner-aeterna-zentaris-completes-patient-recruitment-for-zoptec-phase-3-study-with-zoptarelin-doxorubicin-in-advanced-endometrial-cancer/ 2022-02-15T15:02:35+00:00 https://ergomedgroup.com/news/ergomeds-co-development-partner-ferrer-initiates-phase-iia-study-of-lorediplon-in-patients-with-insomnia/ 2022-02-15T15:02:35+00:00 https://ergomedgroup.com/news/ergomeds-co-development-partner-aeterna-zentaris-announces-data-and-safety-monitoring-board-scheduled-to-complete-second-interim-analysis-of-the-zoptec-phase-3-trial-in-endometrial-cancer-in/ 2022-02-15T15:02:35+00:00 https://ergomedgroup.com/news/ergomed-shortlisted-for-leading-industry-award/ 2022-02-15T15:02:35+00:00 https://ergomedgroup.com/news/ergomed-increases-its-co-development-contribution-in-cel-scis-phase-3-head-and-neck-cancer-trial/ 2022-02-15T15:02:35+00:00 https://ergomedgroup.com/news/ergomed-and-dilaforette-initiate-phase-ii-clinical-trial-with-dilaforettes-sevuparin-in-sickle-cell-disease/ 2022-02-15T15:02:35+00:00 https://ergomedgroup.com/news/ergomed-plc-provides-update-on-co-development-partnerships-2/ 2022-02-15T15:02:35+00:00 https://ergomedgroup.com/news/ergomed-adds-key-capabilities-through-two-german-acquisitions/ 2022-02-15T15:02:35+00:00 https://ergomedgroup.com/news/ergomed-subsidiary-primevigilance-enters-us-market-and-opens-office-in-boston-usa/ 2022-02-15T15:02:35+00:00 https://ergomedgroup.com/news/ergomeds-co-development-partner-aeterna-zentaris-inc-announces-an-additional-two-licensing-deals-for-zoptrex/ 2022-02-15T15:02:35+00:00 https://ergomedgroup.com/news/ergomed-completes-recruitment-of-phase-iia-clinical-trial-of-lorediplon-in-insomnia-in-collaboration-with-co-development-partner-ferrer/ 2022-02-15T15:02:35+00:00 https://ergomedgroup.com/news/ergomed-to-present-at-the-proactive-investors-one2one-investor-forum-on-15th-january-2015/ 2022-02-15T15:02:36+00:00 https://ergomedgroup.com/news/ergomed-and-cel-sci-sign-co-development-agreement-for-multikine-in-head-and-neck-cancer/ 2022-02-15T15:02:36+00:00 https://ergomedgroup.com/news/ergomed-enters-codevelopment-deal-with-ferrer/ 2022-02-15T15:02:36+00:00 https://ergomedgroup.com/news/ergomed-announces-expansion-in-europe-office-is-established-in-ukraine/ 2022-02-15T15:02:36+00:00 https://ergomedgroup.com/news/ergomed-announces-recruitment-of-phase-ii-trial-in-diabetic-neuropathic-pain-has-completed-and-study-is-expected-to-report-later-in-mid-2012/ 2022-02-15T15:02:36+00:00 https://ergomedgroup.com/news/aeterna-zentaris-and-ergomed-sign-co-development-and-profit-sharing-agreement-for-aezs-108-in-endometrial-cancer/ 2022-02-15T15:02:36+00:00 https://ergomedgroup.com/news/primevigilance-was-awarded-a-2014-queens-award-for-enterprise/ 2022-02-15T15:02:36+00:00 https://ergomedgroup.com/wp-content/uploads/2014/07/Dr-Reljanovic-Queen%E2%80%99s-Award-e1405934394967.jpg https://ergomedgroup.com/news/ergomed-plc-provides-update-on-co-development-partnerships/ 2022-02-15T15:02:36+00:00 https://ergomedgroup.com/news/ergomed-to-present-at-the-stifel-2014-healthcare-conference-on-november-18/ 2022-02-15T15:02:36+00:00 https://ergomedgroup.com/news/ergomeds-co-development-partner-aeterna-zentaris-signs-master-collaboration-agreement-with-sinopharm-a-think-for-zoptarelin-doxorubicin-in-china/ 2022-02-15T15:02:36+00:00 https://ergomedgroup.com/news/ergomed-announces-co-development-agreement-with-dilaforette-for-sickle-cell-disease-treatment/ 2022-02-15T15:02:36+00:00 https://ergomedgroup.com/news/ergomed-pharmacovigilance-experts-invited-to-speak-at-dia-usa-annual-meeting-in-june-2015-washington-dc-2/ 2022-02-15T15:02:36+00:00 https://ergomedgroup.com/news/ergomed-strengthens-presence-in-asia-to-meet-increasing-demand-for-drug-development-services/ 2022-02-15T15:02:36+00:00 https://ergomedgroup.com/information-and-resources/whitepaper-accelerating-rare-disease-drug-development-a-strategic-framework-to-guide-planning-for-success/ 2022-02-28T08:45:18+00:00 https://ergomedgroup.com/events/event-dia-global-annual-meeting-2022-chicago-il-4/ 2022-04-13T09:07:24+00:00 https://ergomedgroup.com/wp-content/uploads/2022/04/new-article-banner-DIA-Global-2022-125x125-4.png https://ergomedgroup.com/wp-content/uploads/2022/04/web-news-booth-numbers-300x60-1.png https://ergomedgroup.com/wp-content/uploads/2022/04/Sally-leadership-image-modified-300x300-1.png https://ergomedgroup.com/wp-content/uploads/2022/04/Luis-image-modified-300x300-1.png https://ergomedgroup.com/wp-content/uploads/2022/04/Chris-image-modified-300x300-1.png https://ergomedgroup.com/wp-content/uploads/2022/04/Roy-300x300-1.png https://ergomedgroup.com/events/clinical-operations-in-oncology-trials-west-coast-2022/ 2022-04-21T08:58:25+00:00 https://ergomedgroup.com/wp-content/uploads/2022/04/OCT-West-Oncology-2022-Header-Banner.png https://ergomedgroup.com/wp-content/uploads/2022/04/Deb-Kientop_portrait-circle-300x300-1.png https://ergomedgroup.com/information-and-resources/whitepaper-decentralization-and-innovation-approaches-to-advance-rare-disease-drug-development/ 2022-04-27T20:29:47+00:00 https://ergomedgroup.com/information-and-resources/whitepaper-improving-access-to-cancer-immunotherapy/ 2022-05-17T09:45:33+00:00 https://ergomedgroup.com/events/asco-annual-meeting-2022-2/ 2022-05-20T11:23:49+00:00 https://ergomedgroup.com/wp-content/uploads/2022/05/new-article-banner-ASCO-2022-thumbnail-3-1.png https://ergomedgroup.com/wp-content/uploads/2022/04/ASCO2022-booth-300x60-1.png https://ergomedgroup.com/wp-content/uploads/2022/04/gordana_new_1280x560-modified-300x300-1.png https://ergomedgroup.com/wp-content/uploads/2022/04/Deb-Kientop_office-1-wide-modified-300x300-1.png https://ergomedgroup.com/wp-content/uploads/2022/04/1-MEBONNETERRE19832-modified-300x300-1.png https://ergomedgroup.com/wp-content/uploads/2022/04/1639638883105-modified-300x300-1.png https://ergomedgroup.com/wp-content/uploads/2022/04/1517730603779-modified.png https://ergomedgroup.com/events/asco-annual-meeting-2022/ 2022-05-24T12:12:09+00:00 https://ergomedgroup.com/wp-content/uploads/2022/05/new-article-banner-ASCO-2022-thumbnail-3-15.png https://ergomedgroup.com/wp-content/uploads/2022/04/ASCO2022-booth-300x60-1.png https://ergomedgroup.com/wp-content/uploads/2022/04/gordana_new_1280x560-modified-300x300-1.png https://ergomedgroup.com/wp-content/uploads/2022/04/Deb-Kientop_office-1-wide-modified-300x300-1.png https://ergomedgroup.com/wp-content/uploads/2022/04/1-MEBONNETERRE19832-modified-300x300-1.png https://ergomedgroup.com/wp-content/uploads/2022/04/1639638883105-modified-300x300-1.png https://ergomedgroup.com/wp-content/uploads/2022/04/1517730603779-modified.png https://ergomedgroup.com/events/world-orphan-drug-congress-usa-2022-2/ 2022-06-03T16:11:36+00:00 https://ergomedgroup.com/wp-content/uploads/2022/06/Zizi-portrait-modified.png https://ergomedgroup.com/wp-content/uploads/2022/04/1639638883105-modified-300x300-1.png https://ergomedgroup.com/wp-content/uploads/2022/04/1517730603779-modified.png https://ergomedgroup.com/events/19th-dia-annual-meeting-2022-tokyo-jp/ 2022-09-15T12:31:23+00:00 https://ergomedgroup.com/wp-content/uploads/2022/09/tokyo1-125x125-3.jpg https://ergomedgroup.com/wp-content/uploads/2022/08/DIA-Japan-300x60-1.png https://ergomedgroup.com/events/dia-medical-information-and-communications-conference-barcelona-2022/ 2022-09-19T11:38:53+00:00 https://ergomedgroup.com/wp-content/uploads/2022/09/Capturedia-mi3-125x125-2.png https://ergomedgroup.com/wp-content/uploads/2022/08/MICC-2-300x60-1.png https://ergomedgroup.com/events/the-world-drug-safety-congress-europe-2022-amsterdam-nl-2-10/ 2022-09-22T08:03:33+00:00 https://ergomedgroup.com/wp-content/uploads/2022/09/amsterdam-125x125-2.jpg https://ergomedgroup.com/wp-content/uploads/2022/07/wdsc-europe_2022-300x60-1.png https://ergomedgroup.com/wp-content/uploads/2022/07/Vjera-portrait-full-circle-300x300-1.png https://ergomedgroup.com/wp-content/uploads/2022/04/Sally-leadership-image-modified-300x300-1.png https://ergomedgroup.com/wp-content/uploads/2022/08/Alessandro-web-300x296-1.png https://ergomedgroup.com/wp-content/uploads/2022/07/1602135278516-modified-300x300-1.png https://ergomedgroup.com/events/european-pharmacovigilance-congress-2022-milan-it/ 2022-10-12T11:17:21+00:00 https://ergomedgroup.com/wp-content/uploads/2022/10/m5-125x125-1.jpg https://ergomedgroup.com/wp-content/uploads/2022/10/eu-pv-booth-300x60-1.png https://ergomedgroup.com/wp-content/uploads/2022/10/shaun_photo.jpg https://ergomedgroup.com/wp-content/uploads/2022/10/Noelle-1.jpg https://ergomedgroup.com/wp-content/uploads/2022/08/Alessandro-web-300x296-1.png https://ergomedgroup.com/events/world-orphan-drug-congress-europe-2022/ 2022-11-09T14:10:46+00:00 https://ergomedgroup.com/wp-content/uploads/2022/11/stiges-wodc.png https://ergomedgroup.com/wp-content/uploads/2022/10/web-news-booth-numbers-300x60-1.png https://ergomedgroup.com/wp-content/uploads/2022/06/Zizi-portrait-modified.png https://ergomedgroup.com/wp-content/uploads/2022/04/1-MEBONNETERRE19832-modified-300x300-1.png https://ergomedgroup.com/wp-content/uploads/2022/10/ethel2.jpg https://ergomedgroup.com/wp-content/uploads/2022/10/Corp-Image-modified-300x300-1.png https://ergomedgroup.com/wp-content/uploads/2022/10/Kamel.jpg https://ergomedgroup.com/events/outsourcing-in-clinical-trials-texas-2022-5/ 2022-11-21T14:15:54+00:00 https://ergomedgroup.com/wp-content/uploads/2022/10/Houston-TX-Wordpress-Feature.-3.png https://ergomedgroup.com/wp-content/uploads/2022/09/Kailyn-Bell-300x300-1.png https://ergomedgroup.com/events/dia-global-pharmacovigilance-and-risk-management-strategies-conference-2023-us-14/ 2023-01-05T15:07:00+00:00 https://ergomedgroup.com/wp-content/uploads/2023/01/Global-Pharmacovigilance-and-Risk-Management-Strategies-Conference-125x125-2.jpg https://ergomedgroup.com/wp-content/uploads/2022/12/Global-Pharmacovigilance-and-Risk-Management-Strategies-Conference-300x60-1.png https://ergomedgroup.com/wp-content/uploads/2022/04/Luis-image-modified-300x300-1.png https://ergomedgroup.com/wp-content/uploads/2022/04/Chris-image-modified-300x300-1.png https://ergomedgroup.com/wp-content/uploads/2022/12/ryann-1.jpg https://ergomedgroup.com/wp-content/uploads/2023/01/cecilyy.jpg https://ergomedgroup.com/events/dia-europe-2023-basel-switzerland-2/ 2023-01-20T11:01:30+00:00 https://ergomedgroup.com/wp-content/uploads/2023/01/basel-125x125-11.jpg https://ergomedgroup.com/wp-content/uploads/2023/01/dia-europpe-300x60-1.png https://ergomedgroup.com/wp-content/uploads/2022/04/Sally-leadership-image-modified-300x300-1.png https://ergomedgroup.com/wp-content/uploads/2022/08/Alessandro-web-300x296-1.png https://ergomedgroup.com/wp-content/uploads/2023/01/mathew-300x300-1.jpg https://ergomedgroup.com/wp-content/uploads/2022/07/1602135278516-modified-300x300-1.png https://ergomedgroup.com/events/event-dia-europe-2020-brussels-belgium/ 2023-02-07T08:09:06+00:00 https://ergomedgroup.com/information-and-resources/whitepaper-patient-reported-outcome-in-oncology-clinical-trials/ 2023-02-20T15:52:01+00:00 https://ergomedgroup.com/news/covid-19-whitepaper-the-role-of-il-6-blockers-in-the-treatment-of-patients/ 2023-02-21T16:09:45+00:00 https://ergomedgroup.com/wp-content/uploads/2023/02/Whitepaper.jpg https://ergomedgroup.com/events/chinatrials-16-clinical-development-leaders-summit/ 2024-11-14T23:23:53+00:00 https://ergomedgroup.com/wp-content/uploads/2024/10/Untitled-design-10.jpg https://ergomedgroup.com/events/world-orphan-drug-congress-europe-2024/ 2024-11-14T23:25:41+00:00 https://ergomedgroup.com/wp-content/uploads/2024/10/Untitled-design-10.jpg https://ergomedgroup.com/events/outsourcing-in-clinical-trials-new-england-2024/ 2024-11-14T23:27:09+00:00 https://ergomedgroup.com/wp-content/uploads/2024/10/Untitled-design-10.jpg https://ergomedgroup.com/events/oct-cts-nordics-2024/ 2024-11-14T23:28:43+00:00 https://ergomedgroup.com/wp-content/uploads/2024/10/Untitled-design-10.jpg https://ergomedgroup.com/events/outsourcing-in-clinical-trials-southern-california-2024/ 2024-11-14T23:29:35+00:00 https://ergomedgroup.com/wp-content/uploads/2024/10/Untitled-design-10.jpg https://ergomedgroup.com/events/esmo-congress-2024/ 2024-11-14T23:31:50+00:00 https://ergomedgroup.com/wp-content/uploads/2024/10/Untitled-design-10.jpg https://ergomedgroup.com/events/clinical-trials-in-rare-diseases-2024/ 2024-11-14T23:33:06+00:00 https://ergomedgroup.com/wp-content/uploads/2024/10/Untitled-design-10.jpg https://ergomedgroup.com/events/clinical-operations-in-oncology-east-coast-2024/ 2024-11-14T23:35:22+00:00 https://ergomedgroup.com/wp-content/uploads/2024/10/Untitled-design-10.jpg https://ergomedgroup.com/events/serbian-diaspora-medical-conference-2024/ 2024-11-14T23:36:54+00:00 https://ergomedgroup.com/wp-content/uploads/2024/10/Untitled-design-10.jpg https://ergomedgroup.com/events/bio-international-convention-2024/ 2024-11-14T23:39:43+00:00 https://ergomedgroup.com/wp-content/uploads/2024/10/Untitled-design-10.jpg https://ergomedgroup.com/events/asco-annual-meeting-2024/ 2024-11-14T23:42:08+00:00 https://ergomedgroup.com/wp-content/uploads/2024/10/Untitled-design-10.jpg https://ergomedgroup.com/events/european-pharmacovigilance-congress-2024/ 2024-11-14T23:43:42+00:00 https://ergomedgroup.com/wp-content/uploads/2024/11/Ergomed-Group_news-thumbnails-1.jpg https://ergomedgroup.com/events/world-drug-safety-congress-americas-2024/ 2024-11-14T23:44:12+00:00 https://ergomedgroup.com/wp-content/uploads/2024/11/Ergomed-Group_news-thumbnails-1.jpg https://ergomedgroup.com/events/world-drug-safety-congress-europe-2024/ 2024-11-14T23:45:02+00:00 https://ergomedgroup.com/wp-content/uploads/2024/11/Ergomed-Group_news-thumbnails-1.jpg https://ergomedgroup.com/events/dia-medical-information-and-communications-conference-2024/ 2024-11-14T23:46:03+00:00 https://ergomedgroup.com/wp-content/uploads/2024/11/Ergomed-Group_news-thumbnails-1.jpg https://ergomedgroup.com/events/dia-2024-global-annual-meeting/ 2024-11-14T23:46:50+00:00 https://ergomedgroup.com/wp-content/uploads/2024/11/Ergomed-Group_news-thumbnails-1.jpg https://ergomedgroup.com/events/rqa-international-qa-conference-2024/ 2024-11-14T23:47:44+00:00 https://ergomedgroup.com/wp-content/uploads/2024/11/Ergomed-Group_news-thumbnails-2.jpg https://ergomedgroup.com/news/us-ssu-team-awarded-bronze-in-the-pharmatimes-clinical-researcher-of-the-year-the-americas-2024/ 2024-11-14T23:49:43+00:00 https://ergomedgroup.com/wp-content/uploads/2024/10/Ergomed-Group_news-thumbnails-3.jpg https://ergomedgroup.com/news/cel-sci-selects-ergomed-as-cro-as-it-gears-up-for-confirmatory-fda-registration-study-of-multikine-in-head-and-neck-cancer/ 2024-11-14T23:51:00+00:00 https://ergomedgroup.com/wp-content/uploads/2024/10/Ergomed-Group_news-thumbnails-3.jpg https://ergomedgroup.com/news/124878-17/ 2024-11-14T23:51:11+00:00 https://ergomedgroup.com/wp-content/uploads/2024/10/Ergomed-Group_news-thumbnails-3.jpg https://ergomedgroup.com/wp-content/uploads/2022/06/Zizi-portrait-modified.png https://ergomedgroup.com/news/press-release-ergomed-announces-launch-of-its-rare-disease-innovation-center/ 2024-11-14T23:51:18+00:00 https://ergomedgroup.com/wp-content/uploads/2024/10/Ergomed-Group_news-thumbnails-3.jpg https://ergomedgroup.com/wp-content/uploads/2022/02/RDIC-image-news.png https://ergomedgroup.com/news/dr-marie-edith-bonneterre-appointed-as-ergomed-vice-president-head-of-global-medical-affairs/ 2024-11-14T23:51:26+00:00 https://ergomedgroup.com/wp-content/uploads/2024/10/Ergomed-Group_news-thumbnails-3.jpg https://ergomedgroup.com/wp-content/uploads/2022/01/Marie-announcement-featured-web-2.png https://ergomedgroup.com/news/roger-holden-appointed-as-ergomed-senior-director-quality-assurance/ 2024-11-14T23:51:34+00:00 https://ergomedgroup.com/wp-content/uploads/2024/10/Ergomed-Group_news-thumbnails-3.jpg https://ergomedgroup.com/wp-content/uploads/2021/12/Roger-announcement-9-e1638437915817.png https://ergomedgroup.com/news/zizi-uzezi-imatorbhebhe-appointed-as-the-new-senior-vice-president-global-strategy-development-rare-disease/ 2024-11-14T23:51:42+00:00 https://ergomedgroup.com/wp-content/uploads/2024/10/Ergomed-Group_news-thumbnails-3.jpg https://ergomedgroup.com/wp-content/uploads/2021/11/zizi-web4.jpg https://ergomedgroup.com/news/ronel-steyn-appointed-as-the-new-senior-vice-president-of-global-development/ 2024-11-14T23:51:48+00:00 https://ergomedgroup.com/wp-content/uploads/2024/10/Ergomed-Group_news-thumbnails-3.jpg https://ergomedgroup.com/wp-content/uploads/2021/11/ronel-web-banner-1024x581-1.jpg https://ergomedgroup.com/news/debra-kientop-appointed-as-the-new-vice-president-of-therapeutic-strategy-for-oncology/ 2024-11-14T23:51:57+00:00 https://ergomedgroup.com/wp-content/uploads/2024/10/Ergomed-Group_news-thumbnails-3.jpg https://ergomedgroup.com/wp-content/uploads/2021/10/Deb-Kientop_office-13-scaled-1.jpg https://ergomedgroup.com/news/springer-nature-article-siltuximab-downregulates-interleukin-8-and-pentraxin-3-to-improve-ventilatory-status-and-survival-in-severe-covid-19-co-authored-by-dr-gordana-tonkovic-e/ 2024-11-14T23:52:04+00:00 https://ergomedgroup.com/wp-content/uploads/2024/10/Ergomed-Group_news-thumbnails-3.jpg https://ergomedgroup.com/news/medsource-and-psr-orphan-experts-rebrand-to-ergomed/ 2024-11-14T23:52:11+00:00 https://ergomedgroup.com/wp-content/uploads/2024/10/Ergomed-Group_news-thumbnails-3.jpg https://ergomedgroup.com/wp-content/uploads/2021/04/MedSource-and-PSR-rebrand-social-media-scaled-1.jpg https://ergomedgroup.com/news/press-release-panacea-pharma-projects-limited-rebrands-to-primevigilance/ 2024-11-14T23:53:36+00:00 https://ergomedgroup.com/wp-content/uploads/2024/07/Ergomed-Group_news-thumbnails-4.jpg https://ergomedgroup.com/news/primevigilance-bolsters-global-presence-through-panacea-acquisition/ 2024-11-14T23:53:57+00:00 https://ergomedgroup.com/wp-content/uploads/2024/07/Ergomed-Group_news-thumbnails-4.jpg https://ergomedgroup.com/news/news-sally-amanuel-appointed-as-the-new-president-of-primevigilance/ 2024-11-14T23:54:05+00:00 https://ergomedgroup.com/wp-content/uploads/2024/07/Ergomed-Group_news-thumbnails-4.jpg https://ergomedgroup.com/news/primevigilance-expands-operations-in-japan-press-release/ 2024-11-14T23:54:12+00:00 https://ergomedgroup.com/wp-content/uploads/2024/07/Ergomed-Group_news-thumbnails-4.jpg https://ergomedgroup.com/wp-content/uploads/2021/08/PV-website-Japan-office-4.png https://ergomedgroup.com/news/ergomed-expands-operations-in-japan/ 2024-11-14T23:54:19+00:00 https://ergomedgroup.com/wp-content/uploads/2024/07/Ergomed-Group_news-thumbnails-4.jpg https://ergomedgroup.com/news/enhancing-good-pharmacovigilance-practice-with-adamas-consulting/ 2024-11-14T23:56:18+00:00 https://ergomedgroup.com/wp-content/uploads/2024/06/Ergomed-Group_news-thumbnails-5.jpg https://ergomedgroup.com/news/computer-software-assurance-csa-why-the-change-and-what-does-it-mean/ 2024-11-14T23:56:34+00:00 https://ergomedgroup.com/wp-content/uploads/2024/06/Ergomed-Group_news-thumbnails-5.jpg https://ergomedgroup.com/news/annex-1-revisions-what-are-the-changes-and-whom-will-they-affect/ 2024-11-14T23:56:42+00:00 https://ergomedgroup.com/wp-content/uploads/2024/06/Ergomed-Group_news-thumbnails-5.jpg https://ergomedgroup.com/news/why-is-data-integrity-important-when-transferring-data-in-a-clinical-trial/ 2024-11-14T23:56:48+00:00 https://ergomedgroup.com/wp-content/uploads/2024/06/Ergomed-Group_news-thumbnails-5.jpg https://ergomedgroup.com/news/ergomed-acquires-adamas/ 2024-11-14T23:56:55+00:00 https://ergomedgroup.com/wp-content/uploads/2024/06/Ergomed-Group_news-thumbnails-5.jpg https://ergomedgroup.com/news/ergomed-appoints-dr-sy-pretorius-as-ceo/ 2024-11-14T23:58:54+00:00 https://ergomedgroup.com/wp-content/uploads/2024/07/Ergomed-Group_news-thumbnails-6.jpg https://ergomedgroup.com/news/press-release-ergomed-expands-presence-in-india-with-new-office-in-pune/ 2024-11-14T23:59:22+00:00 https://ergomedgroup.com/wp-content/uploads/2024/07/Ergomed-Group_news-thumbnails-6.jpg https://ergomedgroup.com/news/press-release-ergomed-expands-u-s-presence-with-new-office-in-boston/ 2024-11-14T23:59:30+00:00 https://ergomedgroup.com/wp-content/uploads/2024/07/Ergomed-Group_news-thumbnails-6.jpg https://ergomedgroup.com/news/ergomed-strongly-positioned-for-future-growth-in-new-partnership-with-permira/ 2024-11-14T23:59:37+00:00 https://ergomedgroup.com/wp-content/uploads/2024/07/Ergomed-Group_news-thumbnails-6.jpg https://ergomedgroup.com/news/ergomed-awarded-best-communication-award-at-european-mediscience-awards-2023/ 2024-11-14T23:59:44+00:00 https://ergomedgroup.com/wp-content/uploads/2024/07/Ergomed-Group_news-thumbnails-6.jpg https://ergomedgroup.com/wp-content/uploads/2023/06/Best-Communication-Award.jpg https://ergomedgroup.com/news/ergomed-shortlisted-for-three-awards-at-this-years-european-mediscience-awards-2023/ 2024-11-14T23:59:51+00:00 https://ergomedgroup.com/wp-content/uploads/2024/07/Ergomed-Group_news-thumbnails-6.jpg https://ergomedgroup.com/news/ergomed-shortlisted-for-two-awards-at-this-years-european-mediscience-awards-2022/ 2024-11-14T23:59:58+00:00 https://ergomedgroup.com/wp-content/uploads/2024/07/Ergomed-Group_news-thumbnails-6.jpg https://ergomedgroup.com/news/jefferies-london-healthcare-conference/ 2024-11-15T00:00:08+00:00 https://ergomedgroup.com/wp-content/uploads/2024/07/Ergomed-Group_news-thumbnails-6.jpg https://ergomedgroup.com/news/richard-barfield-cfo-presented-at-the-proactive-one2one-virtual-investor-forum/ 2024-11-15T00:00:16+00:00 https://ergomedgroup.com/wp-content/uploads/2024/07/Ergomed-Group_news-thumbnails-6.jpg https://ergomedgroup.com/news/ergomed-shortlisted-for-two-awards-at-this-years-european-mediscience-awards-2021/ 2024-11-15T00:00:24+00:00 https://ergomedgroup.com/wp-content/uploads/2024/07/Ergomed-Group_news-thumbnails-6.jpg https://ergomedgroup.com/wp-content/uploads/2021/05/1620747876628.jpg https://ergomedgroup.com/news/the-telegraph-covids-silver-lining-article-featuring-ergomed-executive-chairman-dr-miroslav-reljanovic/ 2024-11-15T00:00:41+00:00 https://ergomedgroup.com/wp-content/uploads/2024/07/Ergomed-Group_news-thumbnails-6.jpg https://ergomedgroup.com/events/outsourcing-in-clinical-trials-west-coast-2025/ 2025-01-23T22:20:08+00:00 https://ergomedgroup.com/wp-content/uploads/2025/01/Outsourcing-in-Clinical-Trials-West-Coast-2025.jpg https://ergomedgroup.com/wp-content/uploads/2025/01/Booth-icon-6.png https://ergomedgroup.com/wp-content/uploads/2024/11/Book-a-Meeting-button.png https://ergomedgroup.com/events/j-p-morgan-healthcare-conference-biotech-showcase/ 2025-01-23T22:20:22+00:00 https://ergomedgroup.com/wp-content/uploads/2024/11/JPM-Biotech.jpg https://ergomedgroup.com/wp-content/uploads/2024/11/Book-a-Meeting-button.png https://ergomedgroup.com/wp-content/uploads/2024/11/Lina-Svedlund-modified.png https://ergomedgroup.com/events/dia-global-pharmacovigilance-and-risk-management-strategies-conference-2025/ 2025-01-23T22:24:37+00:00 https://ergomedgroup.com/wp-content/uploads/2025/01/Outsourcing-in-Clinical-Trials-West-Coast-2025.jpg https://ergomedgroup.com/wp-content/uploads/2025/01/Booth-icon-4-150x150-1.png https://ergomedgroup.com/wp-content/uploads/2025/01/Book-a-Meeting-300x85-1.png https://ergomedgroup.com/news/ergomed-ssu-team-named-finalists-in-the-pharmatimes-international-clinical-researcher-of-the-year-2025/ 2025-03-28T01:32:53+00:00 https://ergomedgroup.com/wp-content/uploads/2024/10/Ergomed-Group_news-thumbnails-3.jpg https://ergomedgroup.com/news/adamas-consulting-strengthens-resources-in-apac/ 2025-03-28T01:34:44+00:00 https://ergomedgroup.com/wp-content/uploads/2024/06/Ergomed-Group_news-thumbnails-5.jpg https://ergomedgroup.com/news/ergomed-clinical-research-named-finalist-in-fierce-outsourcing-awards-2026-for-clinical-trial-management/ 2026-04-20T21:17:32+00:00 https://ergomedgroup.com/wp-content/uploads/2026/04/NEWS_Ergomed-Clinical-Research-Named-Finalist-in-Fierce-Outsourcing-Awards-2026-for-Clinical-Trial-Management-1.jpg https://ergomedgroup.com/news/ergomed-group-announces-board-chair-transition/ 2026-04-20T21:17:56+00:00 https://ergomedgroup.com/wp-content/uploads/2026/04/NEWS_Ergomed-Group-Announces-Board-Chair-Transition-2.jpg https://ergomedgroup.com/news/ergomed-featured-by-microsoft-for-enterprise-data-transformation/ 2026-04-20T21:18:03+00:00 https://ergomedgroup.com/wp-content/uploads/2026/03/NEWS_Ergomed-Featured-by-Microsoft-for-Enterprise-Data-Transformation.jpg https://ergomedgroup.com/events/webinar-designing-risk-based-qa-oversight-for-clinical-trials-under-ich-e6-r3/ 2026-04-20T21:23:19+00:00 https://ergomedgroup.com/wp-content/uploads/2026/04/ADM-webinar-480x270-1.png https://ergomedgroup.com/events/cto-west-coast-2026/ 2026-04-20T21:30:01+00:00 https://ergomedgroup.com/wp-content/uploads/2026/04/CTO-West-Coast-2026.png https://ergomedgroup.com/events/oct-europe-2026/ 2026-04-20T21:30:34+00:00 https://ergomedgroup.com/wp-content/uploads/2026/04/OCT-Europe-2026.png https://ergomedgroup.com/events/asco-annual-meeting-2026/ 2026-04-20T21:32:28+00:00 https://ergomedgroup.com/wp-content/uploads/2026/04/ASCO-Annual-Meeting-2026.png